ANGIODYNAMICS INC R&D Expense

Quick Answer

ANGIODYNAMICS INC reported R&D Expense of $26.22 million for fiscal year 2025.

ANGIODYNAMICS INC R&D Expense — Annual History

Fiscal Year R&D Expense YoY Change
2025 $26.22M -16.8%
2024 $31.51M +5.5%
2023 $29.88M -2.8%
2022 $30.74M -15.5%
2021 $36.39M +22.6%
2020 $29.68M +5.0%
2019 $28.26M +16.1%
2018 $24.34M +0.8%
2017 $24.15M -3.6%
2016 $25.05M -5.8%
2015 $26.59M -5.4%
2014 $28.12M +7.8%
2013 $26.09M +27.2%
2012 $20.51M -4.0%
2011 $21.37M +10.9%
2010 $19.27M

Quarterly R&D Expense

Quarter Ending R&D Expense YoY QoQ
November 30, 2025 $7.77M +20.7% +21.1%
August 31, 2025 $6.42M +2.1% -7.2%
February 28, 2025 $6.91M -15.6% +7.4%
November 30, 2024 $6.43M -25.7% +2.4%
August 31, 2024 $6.29M -20.9% -23.3%
February 29, 2024 $8.19M +19.5% -5.4%
November 30, 2023 $8.66M +26.6% +9.0%
August 31, 2023 $7.94M -4.7% +15.9%
  • ANGIODYNAMICS INC showed a decrease of -16.8% in R&D Expense compared to the prior fiscal year.
  • Over the 2010–2025 period, ANGIODYNAMICS INC’s r&d expense has grown by 36.0% (from $19.27 million to $26.22 million).
  • The most recent figure is from ANGIODYNAMICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 18, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment